(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -16.22%37.02B | -10.12%210.22B | -9.48%159.58B | -8.50%102.37B | -11.43%44.19B | -15.14%233.88B | -10.61%176.29B | -8.20%111.88B | 4.25%49.89B | 8.15%275.62B |
Operating income | -16.22%37.02B | -10.12%210.22B | -9.48%159.58B | -8.50%102.37B | -11.43%44.19B | -15.14%233.88B | -10.61%176.29B | -8.20%111.88B | 4.25%49.89B | 8.15%275.62B |
Cost of sales | ---- | 10.96%-172.77B | ---- | 6.06%-84.77B | ---- | 7.55%-194.04B | ---- | 1.42%-90.23B | ---- | -11.65%-209.89B |
Operating expenses | 16.75%-31B | 10.96%-172.77B | 9.08%-129.27B | 6.06%-84.77B | 6.60%-37.24B | 7.55%-194.04B | 3.83%-142.19B | 1.42%-90.23B | -10.10%-39.87B | -11.65%-209.89B |
Gross profit | -13.37%6.02B | -6.02%37.45B | -11.11%30.31B | -18.68%17.61B | -30.67%6.95B | -39.38%39.84B | -30.92%34.1B | -28.64%21.65B | -13.94%10.02B | -1.68%65.73B |
Selling expenses | -2.65%-936.73M | -1.73%-3.69B | -7.15%-2.85B | -4.05%-1.81B | -4.44%-912.59M | 26.10%-3.63B | 24.37%-2.66B | 25.38%-1.74B | 25.19%-873.76M | -1.17%-4.91B |
Administrative expenses | 1.81%-3.18B | -0.56%-21.12B | -3.95%-9.89B | -3.73%-9.48B | 2.33%-3.24B | 26.80%-21B | 4.53%-9.51B | 9.75%-9.14B | 7.48%-3.31B | 5.74%-28.7B |
Research and development expenses | -0.94%-1.07B | ---- | -17.29%-4.58B | ---- | -17.93%-1.06B | ---- | -2.50%-3.91B | ---- | 2.54%-894.88M | ---- |
Profit from asset sales | 724.12%69.42M | ---- | -96.19%37.9M | ---- | -91.26%8.42M | ---- | 146.09%995.86M | ---- | -9.52%96.33M | ---- |
Revaluation surplus | -409.38%-75.52M | ---- | 63.82%-777.95M | ---- | 97.63%-14.83M | ---- | -1,497.06%-2.15B | ---- | -379.10%-625.49M | ---- |
-Changes in the fair value of other assets | -409.38%-75.52M | ---- | 63.82%-777.95M | ---- | 97.63%-14.83M | ---- | -1,497.06%-2.15B | ---- | -379.10%-625.49M | ---- |
Impairment and provision | 32.03%5.55M | 350.97%69.18M | -205.11%-197.69M | -325.65%-260.79M | 105.63%4.2M | 98.38%-27.56M | 113.57%188.07M | 116.57%115.57M | 63.30%-74.6M | ---1.7B |
-Other impairment is provision | 32.03%5.55M | 350.97%69.18M | -205.11%-197.69M | -325.65%-260.79M | 105.63%4.2M | 98.38%-27.56M | 113.57%188.07M | 116.57%115.57M | 63.30%-74.6M | ---1.7B |
Operating interest expense | ---- | ---- | ---- | 10.98%-2.66B | ---- | ---- | ---- | 8.70%-2.99B | ---- | -2.44%-7.25B |
Special items of operating profit | -15.39%486.38M | ---- | -54.60%2.18B | -30.74%1.42B | -67.24%574.86M | ---- | 15.69%4.79B | -11.86%2.05B | 114.19%1.75B | 54.16%8.23B |
Adjustment items of operating profit | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- |
Operating profit | -56.72%694.52M | -16.34%12.7B | -39.54%11.6B | -51.62%4.81B | -70.27%1.6B | -51.64%15.18B | -41.44%19.19B | -38.74%9.94B | -10.12%5.4B | 5.32%31.39B |
Financing cost | 2.24%-1.43B | 12.99%-5.14B | 0.77%-4.09B | ---- | 7.67%-1.47B | ---5.91B | 23.28%-4.12B | ---- | 15.70%-1.59B | ---- |
Share of profits of associates | ---- | -50.37%1.51B | ---- | -47.67%999.32M | ---- | -24.22%3.05B | ---- | 2.91%1.91B | ---- | 22.87%4.02B |
Share of profit from joint venture company | ---- | 56.24%-3.36M | ---- | -136.85%-3.99M | ---- | -77.52%-7.67M | ---- | -329.85%-1.69M | ---- | -419.05%-4.32M |
Special items of earning before tax | -117.76%-20.2M | -39.40%3.45B | 785.94%249.71M | -325.65%-260.79M | 35.73%113.77M | 435.52%5.7B | -57.38%28.19M | 116.57%115.57M | 15.49%83.82M | 43.71%-1.7B |
Earning before tax | -402.77%-760.26M | -30.48%12.52B | -48.59%7.76B | -53.66%5.54B | -93.55%251.1M | -46.57%18.01B | -45.03%15.09B | -31.18%11.97B | -7.16%3.89B | 12.14%33.71B |
Tax | 41.82%-162.01M | 18.69%-2.12B | 46.37%-1.34B | 43.83%-1.13B | 72.03%-278.48M | 67.40%-2.61B | 59.55%-2.5B | 52.14%-2.01B | 12.54%-995.71M | 4.77%-8B |
After-tax profit from continuing operations | -3,268.06%-922.27M | -32.48%10.4B | -49.04%6.42B | -55.65%4.41B | -100.95%-27.38M | -40.10%15.4B | -40.81%12.59B | -24.50%9.95B | -5.16%2.9B | 18.69%25.71B |
Earning after tax | -3,268.06%-922.27M | -32.48%10.4B | -49.04%6.42B | -55.65%4.41B | -100.95%-27.38M | -40.10%15.4B | -40.81%12.59B | -24.50%9.95B | -5.16%2.9B | 18.69%25.71B |
Minority profit | -14.33%427.27M | -9.10%5.99B | -24.80%4.06B | -31.61%2.75B | -54.38%498.77M | -23.60%6.59B | -29.80%5.4B | -17.39%4.01B | 1.81%1.09B | 6.28%8.62B |
Profit attributable to shareholders | -156.49%-1.35B | -49.93%4.41B | -67.26%2.35B | -71.91%1.67B | -129.19%-526.15M | -48.42%8.82B | -47.05%7.19B | -28.65%5.94B | -8.94%1.8B | 26.12%17.09B |
Basic earnings per share | -52.49%0.458 | -74.96%0.166 | -50.10%0.964 | -29.39%0.663 | 29.75%1.932 | |||||
Diluted earnings per share | -53.32%0.45 | -74.96%0.166 | -50.10%0.964 | -29.39%0.663 | 29.75%1.932 | |||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- | -- | Dahua Certified Public Accountants (Special General Partnership), Dahua Ma Shiyun Certified Public Accountants | -- | -- | -- | Tianzhi International Accounting Firm (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data